Skip to main content
PMC home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1988 Aug;64(4):217–218. doi: 10.1136/sti.64.4.217

Treatment failure in Trichomonas vaginalis vaginitis.

W H Lumsden 1, D H Robertson 1, R Heyworth 1, C Harrison 1
PMCID: PMC1194218  PMID: 3049301

Full text

PDF
217

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. DUREL P., ROIRON V., SIBOULET A., BOREL L. J. Systemic treatment of human trichomoniasis with a derivative of nitro-imidazole, 8823 RP. Br J Vener Dis. 1960 Mar;36:21–26. doi: 10.1136/sti.36.1.21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Goulton J., Squires S. Metronidazole-resistant Trichomonas vaginalis. Lancet. 1982 Jan 2;1(8262):42–42. doi: 10.1016/s0140-6736(82)92579-x. [DOI] [PubMed] [Google Scholar]
  3. Lumsden W. H., Harrison C., Robertson D. H. Treatment failure in Trichomonas vaginalis infections in females. II. In-vitro estimation of the sensitivity of the organism to metronidazole. J Antimicrob Chemother. 1988 May;21(5):555–564. doi: 10.1093/jac/21.5.555. [DOI] [PubMed] [Google Scholar]
  4. Meingassner J. G., Heyworth P. G. Intestinal and urogenital flagellates. Antibiot Chemother (1971) 1981;30:163–202. doi: 10.1159/000398097. [DOI] [PubMed] [Google Scholar]
  5. Müller M., Gorrell T. E. Metabolism and metronidazole uptake in Trichomonas vaginalis isolates with different metronidazole susceptibilities. Antimicrob Agents Chemother. 1983 Nov;24(5):667–673. doi: 10.1128/aac.24.5.667. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Müller M. Mode of action of metronidazole on anaerobic bacteria and protozoa. Surgery. 1983 Jan;93(1 Pt 2):165–171. [PubMed] [Google Scholar]
  7. Ralph E. D. Clinical pharmacokinetics of metronidazole. Clin Pharmacokinet. 1983 Jan-Feb;8(1):43–62. doi: 10.2165/00003088-198308010-00003. [DOI] [PubMed] [Google Scholar]
  8. Robertson D. H., Heyworth R., Harrison C., Lumsden W. H. Treatment failure in Trichomonas vaginalis infections in females. I. Concentrations of metronidazole in plasma and vaginal content during normal and high dosage. J Antimicrob Chemother. 1988 Mar;21(3):373–378. doi: 10.1093/jac/21.3.373. [DOI] [PubMed] [Google Scholar]
  9. Robinson S. C. Trichomonal Vaginitis Resistant to Metranidazole. Can Med Assoc J. 1962 Apr 7;86(14):665–665. [PMC free article] [PubMed] [Google Scholar]
  10. Yarlett N., Yarlett N. C., Lloyd D. Ferredoxin-dependent reduction of nitroimidazole derivatives in drug-resistant and susceptible strains of Trichomonas vaginalis. Biochem Pharmacol. 1986 May 15;35(10):1703–1708. doi: 10.1016/0006-2952(86)90327-8. [DOI] [PubMed] [Google Scholar]
  11. Yarlett N., Yarlett N. C., Lloyd D. Metronidazole-resistant clinical isolates of Trichomonas vaginalis have lowered oxygen affinities. Mol Biochem Parasitol. 1986 May;19(2):111–116. doi: 10.1016/0166-6851(86)90115-5. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES